CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Interest Expense
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Interest Expense of $35.00 million for the 3-month period ending 2024-03-30, per its 10-Q filed 2024-05-09.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-05-09
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. interest expense for the quarter ending 2024-03-30 was $35.00M, a 1.81% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. interest expense for the quarter ending 2023-12-30 was $33.54M, a 3.55% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. interest expense for the quarter ending 2023-09-30 was $33.74M, a 196.63% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. interest expense for the quarter ending 2023-07-01 was $35.04M, a 846.37% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. interest expense for fiscal 2023 was $136.71M, a 130.57% increase from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. interest expense for fiscal 2022 was $59.29M, a 19.78% decline from fiscal 2021.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. interest expense for fiscal 2021 was $73.91M, a 14.49% decline from fiscal 2020.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. interest expense for fiscal 2020 was $86.43M, a 41.97% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|---|
| 2024-03-30 | $35.00M 10-Q · filed 2024-05-09 | $68.55M derived: sum of 2 quarters · filed 2024-05-09 | $102.29M derived: sum of 3 quarters · filed 2024-05-09 | $137.33M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2023-12-30 | $33.54M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $67.29M derived: sum of 2 quarters · filed 2024-02-14 | $102.33M derived: sum of 3 quarters · filed 2024-02-14 | $136.71M 10-K · filed 2024-02-14 | |
| 2023-09-30 | $33.74M 10-Q · filed 2023-11-08 | $68.79M derived: sum of 2 quarters · filed 2023-11-08 | $103.17M 10-Q · filed 2023-11-08 | $137.94M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2023-07-01 | $35.04M 10-Q · filed 2023-08-09 | $69.42M 10-Q · filed 2023-08-09 | $104.20M derived: sum of 3 quarters · filed 2024-05-09 | $115.58M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2023-04-01 | $34.38M 10-Q · filed 2024-05-09 | $69.16M derived: sum of 2 quarters · filed 2024-05-09 | $80.53M derived: sum of 3 quarters · filed 2024-05-09 | $84.24M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $34.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $46.15M derived: sum of 2 quarters · filed 2024-02-14 | $49.86M derived: sum of 3 quarters · filed 2024-02-14 | $59.29M 10-K · filed 2024-02-14 | |
| 2022-09-24 | $11.38M 10-Q · filed 2023-11-08 | $15.08M derived: sum of 2 quarters · filed 2023-11-08 | $24.51M 10-Q · filed 2023-11-08 | $36.06M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-06-25 | $3.70M 10-Q · filed 2023-08-09 | $13.14M 10-Q · filed 2023-08-09 | $24.68M derived: sum of 3 quarters · filed 2024-02-14 | $41.14M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-03-26 | $9.43M 10-Q · filed 2023-05-11 | $20.98M derived: sum of 2 quarters · filed 2024-02-14 | $37.44M derived: sum of 3 quarters · filed 2024-02-14 | $53.63M derived: sum of 4 quarters · filed 2024-02-14 | |
| 2021-12-25 | $11.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $28.00M derived: sum of 2 quarters · filed 2024-02-14 | $44.19M derived: sum of 3 quarters · filed 2024-02-14 | $73.91M 10-K · filed 2024-02-14 | |
| 2021-09-25 | $16.45M 10-Q · filed 2022-11-02 | $32.65M derived: sum of 2 quarters · filed 2022-11-02 | $62.36M 10-Q · filed 2022-11-02 | $95.51M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-06-26 | $16.19M 10-Q · filed 2022-08-03 | $45.91M 10-Q · filed 2022-08-03 | $79.06M derived: sum of 3 quarters · filed 2023-02-22 | $97.92M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-03-27 | $29.72M 10-Q · filed 2022-05-04 | $62.87M derived: sum of 2 quarters · filed 2023-02-22 | $81.73M derived: sum of 3 quarters · filed 2023-02-22 | $101.08M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2020-12-26 | $33.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $52.01M derived: sum of 2 quarters · filed 2023-02-22 | $71.37M derived: sum of 3 quarters · filed 2023-02-22 | $86.43M 10-K · filed 2023-02-22 | |
| 2020-09-26 | $18.87M 10-Q · filed 2021-11-03 | $38.22M derived: sum of 2 quarters · filed 2021-11-03 | $53.29M 10-Q · filed 2021-11-03 | $77.65M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-06-27 | $19.35M 10-Q · filed 2021-08-04 | $34.42M 10-Q · filed 2021-08-04 | $58.78M derived: sum of 3 quarters · filed 2022-02-16 | $64.48M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-03-28 | $15.07M 10-Q · filed 2021-05-04 | $39.43M derived: sum of 2 quarters · filed 2022-02-16 | $45.13M derived: sum of 3 quarters · filed 2022-02-16 | $65.96M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2019-12-28 | $24.36M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $30.06M derived: sum of 2 quarters · filed 2022-02-16 | $50.90M derived: sum of 3 quarters · filed 2022-02-16 | $60.88M 10-K · filed 2022-02-16 | |
| 2019-09-28 | $5.70M 10-Q · filed 2020-10-29 | $26.53M derived: sum of 2 quarters · filed 2020-10-29 | $36.52M 10-Q · filed 2020-10-29 | $53.26M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2019-06-29 | $20.84M 10-Q · filed 2020-08-05 | $30.82M 10-Q · filed 2020-08-05 | $47.56M derived: sum of 3 quarters · filed 2021-02-17 | $64.76M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2019-03-30 | $9.99M 10-Q · filed 2020-05-07 | $26.73M derived: sum of 2 quarters · filed 2021-02-17 | $43.92M derived: sum of 3 quarters · filed 2021-02-17 | $62.57M derived: sum of 4 quarters · filed 2021-02-17 | |
| 2018-12-29 | $16.74M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $33.94M derived: sum of 2 quarters · filed 2021-02-17 | $52.58M derived: sum of 3 quarters · filed 2021-02-17 | $63.77M 10-K · filed 2021-02-17 | |
| 2018-09-29 | $17.20M 10-Q · filed 2019-11-06 | $35.84M derived: sum of 2 quarters · filed 2019-11-06 | $47.03M 10-Q · filed 2019-11-06 | $54.76M derived: sum of 4 quarters · filed 2020-02-11 | |
| 2018-06-30 | $18.64M 10-Q · filed 2019-07-31 | $29.83M 10-Q · filed 2019-07-31 | $37.56M derived: sum of 3 quarters · filed 2020-02-11 | $45.23M derived: sum of 4 quarters · filed 2020-02-11 | |
| 2018-03-31 | $11.19M 10-Q · filed 2019-05-07 | $18.91M derived: sum of 2 quarters · filed 2020-02-11 | $26.58M derived: sum of 3 quarters · filed 2020-02-11 | $33.98M derived: sum of 4 quarters · filed 2020-02-11 | |
| 2017-12-30 | $7.72M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11 | $15.39M derived: sum of 2 quarters · filed 2020-02-11 | $22.79M derived: sum of 3 quarters · filed 2020-02-11 | $29.78M 10-K · filed 2020-02-11 | |
| 2017-09-30 | $7.67M 10-Q · filed 2018-11-07 | $15.07M derived: sum of 2 quarters · filed 2018-11-07 | $22.05M 10-Q · filed 2018-11-07 | $29.56M derived: sum of 4 quarters · filed 2019-02-13 | |
| 2017-07-01 | $7.40M 10-Q · filed 2018-08-08 | $14.39M 10-Q · filed 2018-08-08 | $21.90M derived: sum of 3 quarters · filed 2019-02-13 | $28.98M derived: sum of 4 quarters · filed 2019-02-13 | |
| 2017-04-01 | $6.98M 10-Q · filed 2018-05-10 | $14.49M derived: sum of 2 quarters · filed 2019-02-13 | $21.57M derived: sum of 3 quarters · filed 2019-02-13 | $30.48M derived: sum of 4 quarters · filed 2019-02-13 | |
| 2016-12-31 | $7.51M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $14.59M derived: sum of 2 quarters · filed 2019-02-13 | $23.50M derived: sum of 3 quarters · filed 2019-02-13 | $27.71M 10-K · filed 2019-02-13 | |
| 2016-09-24 | $7.08M 10-Q · filed 2017-11-09 | $15.99M derived: sum of 2 quarters · filed 2017-11-09 | $20.20M 10-Q · filed 2017-11-09 | $24.02M derived: sum of 4 quarters · filed 2018-02-13 | |
| 2016-06-25 | $8.91M 10-Q · filed 2017-08-09 | $13.12M 10-Q · filed 2017-08-09 | $16.94M derived: sum of 3 quarters · filed 2018-02-13 | $20.79M derived: sum of 4 quarters · filed 2018-02-13 | |
| 2016-03-26 | $4.21M 10-Q · filed 2017-05-10 | $8.03M derived: sum of 2 quarters · filed 2018-02-13 | $11.88M derived: sum of 3 quarters · filed 2018-02-13 | $16.26M derived: sum of 4 quarters · filed 2018-02-13 | |
| 2015-12-26 | $3.82M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $7.67M derived: sum of 2 quarters · filed 2018-02-13 | $12.05M derived: sum of 3 quarters · filed 2018-02-13 | $15.07M 10-K · filed 2018-02-13 | |
| 2015-09-26 | $3.85M 10-Q · filed 2016-11-02 | $8.23M derived: sum of 2 quarters · filed 2016-11-02 | $11.25M 10-Q · filed 2016-11-02 | $14.03M derived: sum of 4 quarters · filed 2017-02-14 | |
| 2015-06-27 | $4.38M 10-Q · filed 2016-08-03 | $7.40M 10-Q · filed 2016-08-03 | $10.18M derived: sum of 3 quarters · filed 2017-02-14 | $13.18M derived: sum of 4 quarters · filed 2017-02-14 | |
| 2015-03-28 | $3.02M 10-Q · filed 2016-05-04 | $5.80M derived: sum of 2 quarters · filed 2017-02-14 | $8.80M derived: sum of 3 quarters · filed 2017-02-14 | $12.17M derived: sum of 4 quarters · filed 2017-02-14 | |
| 2014-12-27 | $2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $5.78M derived: sum of 2 quarters · filed 2017-02-14 | $9.15M derived: sum of 3 quarters · filed 2017-02-14 | $11.95M 10-K · filed 2017-02-14 | |
| 2014-09-27 | $3.00M 10-Q · filed 2015-11-04 | $6.37M derived: sum of 2 quarters · filed 2015-11-04 | $9.17M 10-Q · filed 2015-11-04 | $12.00M derived: sum of 4 quarters · filed 2016-02-12 | |
| 2014-06-28 | $3.37M 10-Q · filed 2015-07-30 | $6.17M 10-Q · filed 2015-07-30 | $9.00M derived: sum of 3 quarters · filed 2016-02-12 | $11.32M derived: sum of 4 quarters · filed 2016-02-12 | |
| 2014-03-29 | $2.80M 10-Q · filed 2015-04-30 | $5.63M derived: sum of 2 quarters · filed 2016-02-12 | $7.95M derived: sum of 3 quarters · filed 2016-02-12 | $15.49M derived: sum of 4 quarters · filed 2016-02-12 | |
| 2013-12-28 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $5.14M derived: sum of 2 quarters · filed 2016-02-12 | $12.69M derived: sum of 3 quarters · filed 2016-02-12 | $20.97M 10-K · filed 2016-02-12 | |
| 2013-09-28 | $2.32M 10-Q · filed 2014-10-30 | $9.86M derived: sum of 2 quarters · filed 2014-10-30 | $18.14M 10-Q · filed 2014-10-30 | $26.45M derived: sum of 4 quarters · filed 2015-02-17 | |
| 2013-06-29 | $7.54M 10-Q · filed 2014-08-07 | $15.82M 10-Q · filed 2014-08-07 | $24.13M derived: sum of 3 quarters · filed 2015-02-17 | $32.65M derived: sum of 4 quarters · filed 2015-02-17 | |
| 2013-03-30 | $8.28M 10-Q · filed 2014-04-30 | $16.59M derived: sum of 2 quarters · filed 2015-02-17 | $25.11M derived: sum of 3 quarters · filed 2015-02-17 | $33.19M derived: sum of 4 quarters · filed 2015-02-17 | |
| 2012-12-29 | $8.31M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $16.83M derived: sum of 2 quarters · filed 2015-02-17 | $24.91M derived: sum of 3 quarters · filed 2015-02-17 | $33.34M 10-K · filed 2015-02-17 | |
| 2012-09-29 | $8.52M 10-Q · filed 2013-10-30 | $16.60M derived: sum of 2 quarters · filed 2013-10-30 | $25.03M 10-Q · filed 2013-10-30 | $35.00M derived: sum of 4 quarters · filed 2014-02-25 | |
| 2012-06-30 | $8.08M 10-Q · filed 2013-07-31 | $16.51M 10-Q · filed 2013-07-31 | $26.48M derived: sum of 3 quarters · filed 2014-02-25 | $38.42M derived: sum of 4 quarters · filed 2014-02-25 | |
| 2012-03-31 | $8.44M 10-Q · filed 2013-05-08 | $18.40M derived: sum of 2 quarters · filed 2014-02-25 | $30.35M derived: sum of 3 quarters · filed 2014-02-25 | $41.01M derived: sum of 4 quarters · filed 2014-02-25 | |
| 2011-12-31 | $9.97M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $21.91M derived: sum of 2 quarters · filed 2014-02-25 | $32.57M derived: sum of 3 quarters · filed 2014-02-25 | $42.59M 10-K · filed 2014-02-25 | |
| 2011-09-24 | $11.94M 10-Q · filed 2012-11-01 | $22.60M derived: sum of 2 quarters · filed 2012-11-01 | $32.62M 10-Q · filed 2012-11-01 | $42.15M derived: sum of 4 quarters · filed 2013-02-27 | |
| 2011-06-25 | $10.66M 10-Q · filed 2012-08-07 | $20.68M 10-Q · filed 2012-08-07 | $30.20M derived: sum of 3 quarters · filed 2013-02-27 | $42.84M derived: sum of 4 quarters · filed 2013-02-27 | |
| 2011-03-26 | $10.02M 10-Q · filed 2012-05-04 | $19.54M derived: sum of 2 quarters · filed 2013-02-27 | $32.18M derived: sum of 3 quarters · filed 2013-02-27 | $39.29M derived: sum of 4 quarters · filed 2013-02-27 | |
| 2010-12-25 | $9.53M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $22.17M derived: sum of 2 quarters · filed 2013-02-27 | $29.27M derived: sum of 3 quarters · filed 2013-02-27 | $35.28M 10-K · filed 2013-02-27 | |
| 2010-09-25 | $12.64M 10-Q · filed 2011-11-02 | $19.75M derived: sum of 2 quarters · filed 2011-11-02 | $25.75M 10-Q · filed 2011-11-02 | $31.28M derived: sum of 4 quarters · filed 2012-02-27 | |
| 2010-06-26 | $7.10M 10-Q · filed 2011-08-03 | $7.11M 10-Q · filed 2010-08-03 | $13.11M 10-Q · filed 2011-08-03 | $18.64M derived: sum of 3 quarters · filed 2012-02-27 | $24.21M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-03-27 | $6.01M 10-Q · filed 2011-05-04 | $11.53M derived: sum of 2 quarters · filed 2012-02-27 | $17.11M derived: sum of 3 quarters · filed 2012-02-27 | $22.46M derived: sum of 4 quarters · filed 2012-02-27 | |
| 2009-12-26 | $5.53M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $11.10M derived: sum of 2 quarters · filed 2012-02-27 | $16.45M derived: sum of 3 quarters · filed 2012-02-27 | $21.68M 10-K · filed 2012-02-27 | |
| 2009-09-26 | $5.57M 10-Q · filed 2010-11-04 | $10.92M derived: sum of 2 quarters · filed 2010-11-04 | $16.16M 10-Q · filed 2010-11-04 | ||
| 2009-06-27 | $5.35M 10-Q · filed 2010-08-03 | $10.58M 10-Q · filed 2010-08-03 | |||
| 2008-12-27 | $22.34M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |